A
Assertio
Biotech & Life Sciences · Newark, United States · Founded 1995 · IPO 1997
A leading commercial pharmaceutical company bringing differentiated products to patients MoreLess
Assertio Holdings, Inc. is a prominent commercial pharmaceutical company specializing in the development and distribution of branded prescription products. The company focuses on three primary therapeutic areas: neurology, hospital care, and pain and inflammation. Assertio serves a diverse range of clients, including healthcare providers, hospitals, and patients who require specialized medications for chronic and acute conditions. Operating within the pharmaceutical market, Assertio leverages business development strategies such as licensing, mergers, and acquisitions to expand its product portfolio and market reach. The business model is centered around the commercialization of differentiated pharmaceutical products, ensuring compliance with legal and regulatory standards while maintaining high ethical standards. Revenue is generated through the sale of prescription medications, supported by strategic partnerships and a commitment to innovation in therapeutic solutions.
Keywords: pharmaceutical, neurology, hospital care, pain management, prescription products, licensing, mergers, acquisitions, chronic conditions, ethical standards.
Talent graph
Assertio's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Assertio has talent and traffic
team presence
across markets
Patent intelligence
Assertio’s patent portfolio
27 active families in the valuation dataset.
Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.
Market sentiment
What the market is saying about Assertio
An AI-synthesized read of the highest-engagement posts about Assertio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Assertio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



